{"database": "lobbying", "table": "lobbying_activities", "rows": [[1371668, "51182f00-99ee-4ef5-9ec8-a3376bec8d06", "Q1", "MEHLMAN CONSULTING, INC.", 284950, "AMERICAN CLINICAL LABORATORY ASSOCIATION", 2013, "first_quarter", "MMM", "Implementation of Public Law 111-148 (Patient Protection and Affordable Care Act).   \nLegislative proposals and policies impacting Medicare reimbursement for clinical lab services, including co-insurance, copayments, competitive bidding, and fee schedule cuts.\nProposals concerning the Stark Law's in-office ancillary services exception.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office", 80000, null, 0, 0, "2013-04-15T10:18:14.130000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1371668"], "units": {}, "query_ms": 2.049050002824515, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}